ClinicalTrials.gg
Not yet recruitingNCT06587581DTEXT-SBHUpdated Sep 19, 2024

Effectiveness of Text Messaging Intervention to Improve Dietary Behaviors Among Patients with Type 2 Diabetes Mellitus in Low Resource Area of Sabah (DTEXT-SBH)

An interventional study of Control Group and Intervention Group in Type 2 Diabetes Mellitus(T2DM), sponsored by Universiti Malaysia Sabah. Not yet recruiting at 1 site in Malaysia. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Universiti Malaysia Sabah · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia — 19 open to participants now, 19 under way, 6 of them phase 3. Diabetes Mellitus, Type 2 · Malaysia.

Planned enrollment
124th of 149
62 · median 370
Started
2025
with 8 others
No phase
39 of 170
9 open now
Primary completion
2025-07
later than 2 of 18 live
Registered
148th of 170
by date

Among the 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia, this one is the 124th largest by planned enrollment of the 149 interventional ones that give a count, is one of 9 that started in 2025, is one of 39 with no phase, reaches primary completion later than 2 of the 18 other live ones, and was the 148th registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

19 of the 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in Malaysia have not opened yet or have stopped. Only those recruiting at a site in Malaysia →

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if sending three (3) text messages per week over a six (6) months period to people with Type 2 Diabetes in areas with lack access to dietitian could help them stick to a healthier diet. The main questions it aims to answer are:

  • Does a mobile phone text-message intervention improve dietary adherence among T2DM patients?
  • Does a mobile phone text-message intervention improve HbA1c and self-management among T2DM patients? Researchers will compare dietary adherence, HbA1c changes and self-management behaviors between the usual care group and intervention group.

Participants will:

  • Be given three (3) text messages per week over a six (6) months period for the intervention group
  • Both usual care and intervention group will be given standard medical nutrition therapy at baseline, 3rd and 6th months visits to the clinic
03

Conditions studied

  • Type 2 Diabetes Mellitus(T2DM)

Keywords

  • type 2 diabetes mellitus
  • lack access to dietitian
  • eHealth
  • Dietary adherence
  • low resource area
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • have type 2 diabetes.
  • own a mobile phone.
  • able to use WhatsApp.
  • able to read and speak Bahasa Malaysia.
  • have an level above 7.0%.
  • have not seen a dietitian in the previous 6 months.

Exclusion criteria

Exclusion Criteria:

  • individuals with type 1 diabetes mellitus and gestational diabetes mellitus.
  • patients with cognitive impairment affecting memory, attention, language, and problem-solving skills.
  • those with advanced diabetic complications, such as kidney failure and neuropathy.
  • individuals lacking regular access to a mobile phone or with poor network connectivity.
  • pregnant individuals or those planning to get pregnant in the next 6 months, as well as those currently nursing.
  • individuals with major illnesses like cancer or advanced heart disease.
  • those planning major surgery or gastric bypass in the next 6 months.
  • institutionalized individuals, such as those in nursing homes, old folks\' homes, or imprisoned.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
62 participants (estimated)

Study arms

  • Active comparator
    T2DM Medical Nutrition Therapy

    Participants from control groups will receive the usual care, which will be a three-monthly nutrition consultation by a visiting dietitian

    Other: Control Group

  • Experimental
    T2DM Medical Nutrition Therapy and Text Messages

    Participants from the intervention group will receive the usual care and an additional three text messages per week via WhatsApp over the 6-month intervention period

    Other: Intervention Group

Interventions

  • OtherControl Group

    Participants from the intervention group will receive the usual care over the 6-month intervention period

  • OtherIntervention Group

    Participants from the intervention group will receive the usual care and an additional three text messages per week via WhatsApp over the 6-month intervention period

06

What researchers measure

Primary outcomes

  1. Comparison of dietary adherence at 3-month and 6-month between the usual care group and intervention group

    Dietary adherence to diabetic diet will be evaluated against a modified healthy eating index (HEI). A 3-day dietary record methodology (2 weekdays and 1 weekend) will be used and analyzed based on Malaysian and Singapore Food Composition Databases. The modified version of HEI used in this study consists of 14 components. Sum scores of each component yields and overall score of diet quality which will be converted into scale of zero to 100. A higher the HEI score indicates a greater adherence. The overall dietary adherence will be classified as low (below 51%), needing improvement (51-80%), or high (more than 80 points)

    Time frame: Baseline, 3-month, and 6-month

Secondary outcomes

  1. Comparison of glycated hemoglobin (HbA1c) at 3-month and 6-month between the usual care group and intervention group

    Change in HbA1c will be determined by blood test at baseline, 3 and 6 months. The HbA1c result will be retrieved from the participants' routine blood result at health clinic or hospital, which will be analyzed following a standardized analytic protocol of Ministry of Health, Malaysia

    Time frame: Baseline, 3-month, and 6-month

  2. Comparison of self-management behavior at 3-month and 6-month between the usual care group and intervention group

    The Malay version of the Summary of Diabetes Self-Care Activities (SDSCA) will be used to measure diabetes self-management activities. The SDSCA will be used to examine the participants' compliance in performing five main self-care activities. The degree of compliance or frequency with which the person engages in each self-care behavior is considered when interpreting the SDSCA scores. Higher ratings across the board typically suggest better adherence and more active diabetes self-management.

    Time frame: Baseline, 3-month, and 6-month

07

Study locations

1 site
  • Ranau District Hospital and Klinik Kesihatan Kundasang
    Kota Kinabalu, Sabah 89308, Malaysia
08

References and documents

Publications

  • Arora S, Peters AL, Burner E, Lam CN, Menchine M. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med. 2014 Jun;63(6):745-54.e6. doi: 10.1016/j.annemergmed.2013.10.012. Epub 2013 Nov 11. Erratum In: Ann Emerg Med. 2017 Jun;69(6):802. doi: 10.1016/j.annemergmed.2017.04.041. PubMed 24225332 ↗
  • Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, Shetty AS, Godsland IF, Chaturvedi N, Majeed A, Oliver N, Toumazou C, Alberti KG, Johnston DG. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2013 Nov;1(3):191-8. doi: 10.1016/S2213-8587(13)70067-6. Epub 2013 Sep 11. PubMed 24622367 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2025; primary completion for Jul 2025, 6 months later.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 6 months is below that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 5, 2024
First posted
Sep 19, 2024
StartEst.
Jan 2025
Primary completionEst.
Jul 2025
CompletionEst.
Jul 2025
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06587581
Lead sponsor
Universiti Malaysia Sabah
Responsible party
ESTHER ALIM ALBERT (REGISTERED DIETITIAN, Universiti Malaysia Sabah) — Principal investigator
First posted
Sep 19, 2024
Start date
Jan 2025 (estimated)
Primary completion
Jul 2025 (estimated)
Completion
Jul 2025 (estimated)
Last update
Sep 19, 2024

Study contacts

Esther Alim Albert
Contact
esther_alim_mn22@iluv.ums.edu.my
6088320000
Esther Alim Albert
Contact

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion